Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | PLX-4720 | 1 | uM | 2 | 312.50 | 134.46 | 2041.00 | 2027.50 | 1.0067 | 1.0034 |
| MCF 10A | PLX-4720 | 0.031623 | uM | 2 | 312.50 | 134.46 | 1776.00 | 2027.50 | 0.8760 | 0.9335 |
| MCF 10A | 0 | uM | 2 | 312.50 | 134.46 | 1586.00 | 2027.50 | 0.7822 | 0.8784 | |
| MCF 10A | 0 | uM | 2 | 312.50 | 134.46 | 1358.00 | 2027.50 | 0.6698 | 0.8054 | |
| MCF 10A | 0 | uM | 2 | 312.50 | 134.46 | 1393.00 | 2027.50 | 0.6871 | 0.8171 | |
| MCF 10A | 0 | uM | 2 | 312.50 | 134.46 | 1345.00 | 2027.50 | 0.6634 | 0.8009 | |
| MCF 10A | Etoposide | 0.01 | uM | 2 | 312.50 | 134.46 | 1689.00 | 2027.50 | 0.8331 | 0.9088 |
| MCF 10A | Etoposide | 0.31623 | uM | 2 | 312.50 | 134.46 | 460.00 | 2027.50 | 0.2269 | 0.3692 |
| MCF 10A | PLX-4720 | 0.1 | uM | 2 | 312.50 | 134.46 | 2396.00 | 2027.50 | 1.1818 | 1.0872 |
| MCF 10A | Nilotinib | 0.01 | uM | 2 | 312.50 | 134.46 | 2066.00 | 2027.50 | 1.0190 | 1.0096 |
| MCF 10A | Nilotinib | 0.1 | uM | 2 | 312.50 | 134.46 | 2706.00 | 2027.50 | 1.3346 | 1.1531 |
| MCF 10A | Etoposide | 19.9526 | uM | 2 | 312.50 | 134.46 | 77.00 | 2027.50 | 0.0380 | -0.1327 |
| MCF 10A | PLX-4720 | 0.01 | uM | 2 | 312.50 | 134.46 | 2499.00 | 2027.50 | 1.2326 | 1.1097 |
| MCF 10A | PLX-4720 | 3.1623 | uM | 2 | 312.50 | 134.46 | 2100.00 | 2027.50 | 1.0358 | 1.0180 |
| MCF 10A | Nilotinib | 10 | uM | 2 | 312.50 | 134.46 | 605.00 | 2027.50 | 0.2984 | 0.4685 |
| MCF 10A | NVP-TAE684 | 0.0016596 | uM | 2 | 312.50 | 134.46 | 2428.00 | 2027.50 | 1.1975 | 1.0943 |
| MCF 10A | Nilotinib | 1 | uM | 2 | 312.50 | 134.46 | 2565.00 | 2027.50 | 1.2651 | 1.1238 |
| MCF 10A | NVP-TAE684 | 0.1 | uM | 2 | 312.50 | 134.46 | 1403.00 | 2027.50 | 0.6920 | 0.8205 |
| MCF 10A | PLX-4720 | 10 | uM | 2 | 312.50 | 134.46 | 1724.00 | 2027.50 | 0.8503 | 0.9188 |
| MCF 10A | Nilotinib | 19.9526 | uM | 2 | 312.50 | 134.46 | 282.00 | 2027.50 | 0.1391 | 0.2083 |
| MCF 10A | 0 | uM | 2 | 312.50 | 134.46 | 2555.00 | 2027.50 | 1.2602 | 1.1217 | |
| MCF 10A | NVP-TAE684 | 3.1623 | uM | 2 | 312.50 | 134.46 | 148.00 | 2027.50 | 0.0730 | 0.0248 |
| MCF 10A | Etoposide | 0.0033113 | uM | 2 | 312.50 | 134.46 | 1950.00 | 2027.50 | 0.9618 | 0.9802 |
| MCF 10A | PLX-4720 | 19.9526 | uM | 2 | 312.50 | 134.46 | 775.00 | 2027.50 | 0.3822 | 0.5644 |
| MCF 10A | Etoposide | 3.1623 | uM | 2 | 312.50 | 134.46 | 80.00 | 2027.50 | 0.0395 | -0.1242 |